Valuation: Stereotaxis, Inc.

Market Cap 99.69M 88.98M 82.09M 74.58M 140M 9.44B 142M 989M 390M 4.95B 374M 366M 15.67B P/E 2026 *
-4.91x
P/E 2027 * -6.8x
Enterprise Value 99.69M 88.98M 82.09M 74.58M 140M 9.44B 142M 989M 390M 4.95B 374M 366M 15.67B EV / Sales 2026 *
2.9x
EV / Sales 2027 * 2.18x
Free-Float
84.79%
Yield 2026 *
-
Yield 2027 * -
1 day+0.31%
1 week-4.95%
Current month-18.86%
1 month-28.71%
3 months-33.02%
6 months-48.56%
Current year-56.61%
1 week 0.95
Extreme 0.95
1.05
1 month 0.95
Extreme 0.95
1.33
Current year 0.95
Extreme 0.95
2.86
1 year 0.95
Extreme 0.95
3.15
3 years 0.95
Extreme 0.95
3.59
5 years 0.95
Extreme 0.95
7.22
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 2017-02-02
Director of Finance/CFO 57 2019-09-30
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 2005-01-31
Chairman - 2017-02-02
Director/Board Member 71 2016-09-28
Date Insider Type Main position Quantity % Market Cap. Importance
7/1/26 Free

Director

43,103 0.0441%
7/1/26 Free

Director

43,103 0.0441%
7/1/26
DAFNA Capital Management LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%-4.95%-67.17%-34.77% 99.69M
-2.52%-2.86%+19.28%+45.69% 250B
-1.76%-0.76%+5.34%+11.62% 162B
+3.67%+3.74%-15.78%+66.29% 154B
+3.37%+4.24%-55.70%-8.07% 66.68B
+0.18%+0.84%-15.32%-11.01% 52.08B
+0.62%+3.04%+11.25%+60.96% 52.22B
+1.91%+2.26%+17.24%+29.66% 51.93B
-2.17%-0.95%+19.21%+59.20% 49.02B
-0.41%+2.58%+30.67%+79.62% 44.76B
Average -0.21%+0.86%-5.10%+29.92% 88.24B
Weighted average by Cap. -0.50%+0.54%+2.87%+38.06%

Financials

2026 *2027 *
Net sales 34.33M 30.65M 28.27M 25.69M 48.19M 3.25B 48.93M 341M 134M 1.7B 129M 126M 5.4B 45.67M 40.76M 37.61M 34.17M 64.09M 4.33B 65.08M 453M 178M 2.27B 171M 168M 7.18B
Net income -20.13M -17.97M -16.58M -15.06M -28.26M -1.91B -28.69M -200M -78.68M -999M -75.57M -73.95M -3.17B -14.77M -13.18M -12.16M -11.05M -20.73M -1.4B -21.04M -146M -57.71M -733M -55.43M -54.24M -2.32B
Net Debt - -
Projected Income Statement - Annual - Stereotaxis, Inc.
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
26-10-22 US$0.9980 +0.31% 381,713
26-10-21 US$0.9949 -0.34% 615,328
26-10-20 US$0.9983 -1.16% 637,378
26-10-19 US$1.010 0.00% 889,682
26-10-16 US$1.010 -3.81% 870,063
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Stereotaxis, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.9980USD
Average target price
3.000USD
Spread / Average Target
+200.60%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Stereotaxis, Inc.
  1. Stock Market
  2. Stocks
  3. STXS Stock